BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
188 hedge funds and large institutions have $3.5B invested in Blueprint Medicines in 2018 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 64 increasing their positions, 64 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 64
0.03% less ownership
Funds ownership: 102.23% → 102.2% (-0.03%)
34% less call options, than puts
Call options by funds: $13.9M | Put options by funds: $20.9M
Holders
188
Holding in Top 10
7
Calls
$13.9M
Puts
$20.9M
Top Buyers
| 1 | +$50.3M | |
| 2 | +$46.5M | |
| 3 | +$44.2M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$23.1M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$19.7M |
Top Sellers
| 1 | -$47.2M | |
| 2 | -$32.4M | |
| 3 | -$20.1M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$18.6M |
| 5 |
Two Sigma Investments
New York
|
-$18.3M |